Sarah Owermohle

Sarah's articles focus predominantly on government announcements and legal policy regulation within the healthcare, pharmaceutical, and political domains. She is likely to be interested in expert insights related to these areas, including analysis of government policies, regulatory changes, and their impacts on healthcare and pharmaceutical industries.

Given her coverage attributes, she seems particularly responsive to pitches with perspectives from policymakers or experts familiar with legislative processes impacting healthcare regulations or pharmaceutical industry practices.

As Sarah’s geographic focus is not specified but most of her reporting pertains to U.S. institutions such as the FDA and CDC, pitching sources who can provide valuable commentary specific to these organizations' activities may resonate well with her coverage interests.